Pro-Dex, Inc. (PDEX)
| Market Cap | 186.31M +85.9% |
| Revenue (ttm) | 79.58M +13.3% |
| Net Income | 12.03M +7.5% |
| EPS | 3.64 +9.7% |
| Shares Out | 3.20M |
| PE Ratio | 15.99 |
| Forward PE | 18.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 38,474 |
| Open | 63.15 |
| Previous Close | 61.60 |
| Day's Range | 57.62 - 65.65 |
| 52-Week Range | 28.81 - 77.00 |
| Beta | 0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About PDEX
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace a... [Read more]
Financial Performance
In fiscal year 2026, Pro-Dex's revenue was $77.55 million, an increase of 16.45% compared to the previous year's $66.59 million. Earnings were $13.66 million, an increase of 52.17%.
Financial StatementsNews
Pro-Dex reports Q3 EPS 92c vs. $1.40 last year
Reports Q3 revenue $20.56M vs. $18.53M last year. Richard Van Kirk, the Company’s President and Chief Executive Officer, commented, “We are pleased with our first quarter results and continued top…
Pro-Dex Quarterly report: Q1 2027
Pro-Dex has published its Q1 2027 quarterly earnings report on October 29, 2026.
Pro-Dex Earnings release: Q1 2027
Pro-Dex released its Q1 2027 earnings on October 29, 2026, summarizing the period's financial results.
Pro-Dex Proxy statement: Proxy filing
Pro-Dex filed a proxy statement on October 6, 2026, providing details for shareholder voting and corporate governance matters.
Pro-Dex Proxy statement: Proxy filing
Pro-Dex filed a proxy statement on October 6, 2026, providing details for shareholder voting and corporate governance matters.
Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
IRVINE, CA / ACCESS Newswire / September 3, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.
Pro-Dex Annual report: Q4 2026
Pro-Dex has published its Q4 2026 annual report on September 3, 2026.
Pro-Dex Earnings release: Q4 2026
Pro-Dex released its Q4 2026 earnings on September 3, 2026, summarizing the period's financial results.
Pro-Dex Transcript: Planet MicroCap Las Vegas 2026
A decade of turnaround and growth has positioned the company as a leader in surgical power tools, leveraging proprietary torque-limiting technology and expanding through acquisitions and new product development. Diversification, strong customer relationships, and operational investments underpin aggressive future growth plans.
Pro-Dex Slides: Investor presentation
Pro-Dex has posted slides in relation to its latest quarterly earnings report, which was published on June 16, 2026.
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026.
Pro-Dex Quarterly report: Q3 2026
Pro-Dex has published its Q3 2026 quarterly earnings report on April 30, 2026.
Pro-Dex Earnings release: Q3 2026
Pro-Dex released its Q3 2026 earnings on April 30, 2026, summarizing the period's financial results.
Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining
IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"), for...
Pro-Dex reports Q2 EPS 66c vs. 61c last year
Reports Q2 revenue $18.7M vs. $16.8M last year. The 11% increase in revenue was primarily driven by a $7.3M increase in shipments of the company’s largest customer’s next-generation orthopedic handpie...
Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
IRVINE, CA / ACCESS Newswire / January 29, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025.
Pro-Dex Earnings release: Q2 2026
Pro-Dex released its Q2 2026 earnings on January 29, 2026, summarizing the period's financial results.
Pro-Dex Quarterly report: Q2 2026
Pro-Dex has published its Q2 2026 quarterly earnings report on January 29, 2026.
Pro-Dex announces contract extension with largest customer
Pro-Dex (PDEX) announced that on December 17, 2025, it executed a contract amendment with its largest customer for an additional three years. The contract, which was scheduled to terminate on…
Pro-Dex, Inc. Announces Contract Extension With Largest Customer
IRVINE, CA / ACCESS Newswire / December 19, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on December 17, 2025, it executed a contract amendment with its largest customer for an additional...
Pro-Dex, Inc. Announces Fiscal 2026 First Quarter Results
IRVINE, CA / ACCESS Newswire / October 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 first quarter ended September 30, 2025.
Pro-Dex Earnings release: Q1 2026
Pro-Dex released its Q1 2026 earnings on October 30, 2025, summarizing the period's financial results.
Pro-Dex Quarterly report: Q1 2026
Pro-Dex has published its Q1 2026 quarterly earnings report on October 30, 2025.
Pro-Dex, Inc. Announces Clarification Related to Trading Symbol
IRVINE, CA / ACCESS Newswire / October 16, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) is issuing this press release in an effort to help avoid any confusion in the marketplace between the common stock of Pr...
Pro-Dex Proxy statement: Proxy Filing
Pro-Dex filed a proxy statement on October 7, 2025, providing details for shareholder voting and corporate governance matters.